These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14254700)

  • 1. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN MYOCARDIAL INFARCTS IN RATS.
    KWAAN HC; ASTRUP T
    Thromb Diath Haemorrh; 1964 Dec; 12():407-17. PubMed ID: 14254700
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged activation of fibrinolytic system induced by fibrin nonselective thrombolytic agent can contribute to preventing early reocclusion after coronary thrombolytic therapy.
    Goto S; Kawai Y; Handa S; Takahashi E; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Cardiology; 1993; 82(4):274-9. PubMed ID: 8402754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIBRINOLYTIC ACTIVITY OF TISSUE SECTIONS OF THE DOG KIDNEY.
    PROKOPOWICZ J; REJNIAK L; NIEWIAROWSKI S; WOROWSKI K
    Thromb Diath Haemorrh; 1964 Dec; 12():396-406. PubMed ID: 14254699
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIBRINOLYTIC ACTIVITY OF COMMERCIAL THROMBINS AND THEIR INFLUENCE ON THE ACCURACY OF THE STANDARD FIBRIN PLATE METHOD].
    SCHULTE W
    Thromb Diath Haemorrh; 1965 Jun; 13():561-71. PubMed ID: 14347877
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer thrombolytic drugs for acute myocardial infarction.
    Reddy DS
    Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique.
    Kwaan HC; Astrup T
    Lab Invest; 1967 Aug; 17(2):140-5. PubMed ID: 6053020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic therapy in acute myocardial infarct].
    Aschermann M; Horák J; Reznícek V; Bĕlohlávek J; Aschermann O
    Cas Lek Cesk; 2003; 142(10):582-5. PubMed ID: 14635419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic mechanisms and regulation of fibrinolysis.
    Longstaff C; Kolev K
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S98-105. PubMed ID: 26149056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-specific thrombolytic agents.
    Collen D
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units.
    Longstaff C; Whitton CM
    J Thromb Haemost; 2004 Aug; 2(8):1416-21. PubMed ID: 15304049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
    Gurewich V
    J Am Coll Cardiol; 2016 Nov; 68(19):2099-2106. PubMed ID: 27810050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational initiatives in thrombolytic therapy.
    Klegerman ME
    Front Med; 2017 Mar; 11(1):1-19. PubMed ID: 28116631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.